Loading...
Chemical structure of Maraviroc

GC15090

Maraviroc

Also known as 4,4-difluoro-N-[(1S)-3-[(1S,5R)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide

Maraviroc, the first CCR5 antagonist, has been approved for the treatment of HIV infection, IC50 on hERG ion channel＞10μM

ChemicalCAS376348-65-1MW513.67FormulaC29H41F2N5O
CAS number
376348-65-1
Molecular weight
513.67
Formula
C29H41F2N5O
Solubility
≥ 25·7mg/mL in DMSO, ≥ 48 mg/mL in EtOH
InChIKey
GSNHKUDZZFZSJB-HLMSNRGBSA-N
Catalogue number
GC15090
Brand
GLPBIO
Computed properties PubChem CID 3002977 · XLogP 5.1 · TPSA 63.1 Ų · H-bond donors 1
XLogP
5.1
TPSA
63.1 Ų
H-bond donors
1
H-bond acceptors
6
Rotatable bonds
8
Heavy atoms
37

SMILES CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C

Computed descriptors from PubChem (CID 3002977), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.